PT910575E - Lipossomas fusogenicos - Google Patents

Lipossomas fusogenicos

Info

Publication number
PT910575E
PT910575E PT97927386T PT97927386T PT910575E PT 910575 E PT910575 E PT 910575E PT 97927386 T PT97927386 T PT 97927386T PT 97927386 T PT97927386 T PT 97927386T PT 910575 E PT910575 E PT 910575E
Authority
PT
Portugal
Prior art keywords
peptide
formula
defined above
optionally
substituted
Prior art date
Application number
PT97927386T
Other languages
English (en)
Inventor
Chitoshi Hatanaka
Yasuaki Abe
Mitsuhisa Yamano
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PT910575E publication Critical patent/PT910575E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PT97927386T 1996-06-21 1997-06-19 Lipossomas fusogenicos PT910575E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16179196 1996-06-21

Publications (1)

Publication Number Publication Date
PT910575E true PT910575E (pt) 2003-02-28

Family

ID=15741986

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97927386T PT910575E (pt) 1996-06-21 1997-06-19 Lipossomas fusogenicos

Country Status (13)

Country Link
US (1) US6211333B1 (pt)
EP (1) EP0910575B1 (pt)
KR (1) KR100459978B1 (pt)
CN (1) CN1129607C (pt)
AT (1) ATE224912T1 (pt)
AU (1) AU3189997A (pt)
CA (1) CA2257381C (pt)
DE (1) DE69715860T2 (pt)
DK (1) DK0910575T3 (pt)
ES (1) ES2184096T3 (pt)
IL (3) IL127312A0 (pt)
PT (1) PT910575E (pt)
WO (1) WO1997048726A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
ATE455106T1 (de) 1999-01-22 2010-01-15 Elan Pharm Inc Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
EP1144435B1 (en) * 1999-01-26 2006-04-12 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
WO2001002428A1 (en) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Process for the preparation of lh-rh derivatives
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
ES2444215T3 (es) * 2002-07-29 2014-02-24 Zymtech Production As Método para la producción de péptidos y aminoácidos a partir de material de origen animal que comprende proteínas
ES2336826T3 (es) * 2005-05-03 2010-04-16 Novetide, Ltd. Procedimientos para la produccion de un peptido que presenta una amida c-terminal.
BRPI0616687A2 (pt) 2005-09-29 2011-06-28 Elan Pharm Inc compostos de pirimidinil amida que inibem a adesão leucocitária mediada por vla-4
CA2624524C (en) 2005-09-29 2014-07-08 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
CA2643838A1 (en) 2006-02-27 2007-09-07 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
WO2010126914A1 (en) 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins
JP6564539B1 (ja) * 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
CN113527438A (zh) * 2021-08-30 2021-10-22 湖南三太药业有限公司 一种全液相合成丙氨瑞林的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947569A (en) * 1972-04-12 1976-03-30 American Home Products Corporation Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor
US3855198A (en) 1972-09-29 1974-12-17 American Home Prod Novel intermediates for synthesis of l-(5-oxoprolyl)-l-histidy-l-tryptophyl-l-seryl-l-tyrosyl-l-glycyl-l-leucyl-l-arginyl-l-prolyl-glycine amide
JPS49100081A (pt) 1973-01-30 1974-09-20
CA1023350A (en) 1974-01-21 1977-12-27 Manfred K. Gotz Derivatives of the lh- and fsh-releasing hormone
CH611878A5 (pt) 1974-07-04 1979-06-29 Takeda Chemical Industries Ltd
DE3163800D1 (en) 1980-02-12 1984-07-05 Takeda Chemical Industries Ltd Method for protecting guanidino group and restoring the same
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
DE68928278T2 (de) 1988-02-10 1998-03-12 Tap Pharmaceuticals Inc Lhrh-analog

Also Published As

Publication number Publication date
CA2257381C (en) 2007-08-21
US6211333B1 (en) 2001-04-03
KR20000016798A (ko) 2000-03-25
IL163521A (en) 2007-07-04
KR100459978B1 (ko) 2005-01-15
ES2184096T3 (es) 2003-04-01
CN1129607C (zh) 2003-12-03
AU3189997A (en) 1998-01-07
EP0910575B1 (en) 2002-09-25
DE69715860T2 (de) 2003-08-07
CN1222916A (zh) 1999-07-14
WO1997048726A1 (en) 1997-12-24
CA2257381A1 (en) 1997-12-24
IL127312A0 (en) 1999-09-22
DE69715860D1 (de) 2002-10-31
ATE224912T1 (de) 2002-10-15
IL163521A0 (en) 2005-12-18
DK0910575T3 (da) 2003-02-03
EP0910575A1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
PT910575E (pt) Lipossomas fusogenicos
ES486572A1 (es) Procedimiento para la fabricacion de acidos treo-3-amino-2- hidroxibutanoil amonoaceticos.
ES2000910A6 (es) Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos
KR880003974A (ko) 디아민의 선택적 아미딘화 방법
ES8200645A1 (es) Un procedimiento para la preparacion de un muramildipeptido.
ZA801543B (en) Pharmaceutical heterocyclic compounds and compositions
ES8704974A1 (es) Procedimiento para la obtencion de derivados de oligopeptido, de efecto tensioactivo compatible con la piel
ES476919A1 (es) Procedimiento para la preparacion de nuevos compuestos de 2-pirrolidona.
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
IE41052B1 (en) Crop protection composition and method of application, whereby the drift of spraying liquids may be reduced
HU896606D0 (en) Process for the preparation of aminoacid derivatives inhibiting enzymes and pharmaceutical compositions thereof
WO1999003817A3 (en) Aliphatic propargylamines as cellular rescue agents
JPS6429347A (en) Amide derivative and external agent for skin containing said derivative
MX9404647A (es) Composicion combustible.
ES453304A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoacidos.
JPS5655359A (en) Halogenated alpha-amino acid, and its preparation
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
ZA877862B (en) The synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
ES8105970A1 (es) Procedimiento para preparar acidos metil aminoalcanoicos fluorados.
ES8207517A1 (es) Un procedimiento para obtener derivados de biciclooctano
JPS57123155A (en) Preparation of pyrrolidine derivative and its intermediate
UA42798C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, проміжні сполуки, фармацевтична композиція на основі аналогів 15-дезоксипергуаліну
ES8106695A1 (es) Un procedimiento para la pre-paracion de un peptido.
GB1565412A (en) Sulphur-containing n-(o-nitro-benzyl)-amino acids and esters
JPS572214A (en) Cosmetic